From late action to detection and prevention
Medics diagnose Chronic Inflammatory Diseases only after tissue and organ damage has occurred and are unable to reliably identify the most vulnerable patients to prevent development of the disease at the early stage.
From imprecision to personalised treatment
For many syndromic IDs, medics cannot readily distinguish between the different possible types of immune dysfunction, so they use imprecise therapies that alleviate symptoms rather than identify and treat causes.
From expensive to affordable and accessible to all
The lack of affordable and scalable prognostic and predictive tests leads to mounting healthcare costs. Patients with the worst health outcomes are only identified when they have serious inflammatory episodes. Hence costs to treat them are significantly higher.
